The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

In what setting is abatacept most effective as GvHD prophylaxis?

During the 2021 TCT Meetings Digital Experience, the GvHD Hub spoke to Muna Qayed, Winship Cancer Institute of Emory University, Atlanta, US. We asked, In what setting is abatacept most effective as GvHD prophylaxis?

In what setting is abatacept most effective as GvHD prophylaxis?

In this video, Qayed discusses a multicenter phase II trial that looks at the addition of abatacept to standard GvHD prophylaxis in patients with hematological malignancies undergoing transplantation. Qayed believes abatacept could significantly open up the donor pool for patients who don't have a well-matched donor in the registry.

 

Share:
More about...